Oxford, United Kingdom · Health Care · Form D filed Sep 28, 2026
Pictura Bio US, Inc. raised $15M
Pictura Bio US, Inc. is a biotechnology company based in Oxford, United Kingdom. In a Form D filed with the SEC on September 28, 2026, it reported raising $15,000,000 from 20 investors as part of an offering of up to $15,000,000. The first sale in the offering took place on August 12, 2026.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
$24.1M raised since 2020
2 Form D offerings, as reported to the SEC, the first in Sep 28, 2026. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 28, 2026 | $9.1M | $17.5M | 6 |
| Sep 28, 2026 | $15M | $15M | 20 |
Lead score
39 out of 100
filed recently first raise ever budget to spend young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $15,000,000
- Offering size
- $15,000,000
- Investors so far
- 20
- First sale
- August 12, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Oxford, United Kingdom
- Incorporated
- Delaware, 2026
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $15,000,000 | $15,000,000 | 20 | SEC filing | |
| D (new notice) | $9,125,915 | $17,460,598 | 6 | SEC filing |
Figures come from the company's own filings with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 28, 2026 · September 2026 funding report
Similar raises
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
J3 Bioscience, Inc.
Salt Lake City, UT · filed Oct 1612th Form D since 2012
Ensho Therapeutics, Inc.
Woodcliff Lake, NJ · filed Oct 155th Form D since 2024Still raising
Light Wave Ownership Path, LLC
Raleigh, NC · filed Oct 1512th Form D since 2019
Immuno Cancer Biotherapeutics, Inc.
Canton, SD · filed Oct 15First Form D